Summary
58 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 70% a year over the last 3 years.
- Out of every 100 INR of revenue, 11 INR is left as net profit.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 44.6 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (INR)
Diluted EPS (INR)
- Analyst estimate
Revenue grew by 17% a year over 5 years. Over the last 3 years it grew by 18% a year. Earnings per share grew by 70% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 INR of revenue goes
- Cost of sales 42 INR
- Sales and administration 40 INR
- Taxes and other 7.2 INR
- Net profit 11 INR
Net profit, industry median (Medical - Care Facilities) 6.8 INR
Out of every 100 INR of revenue, 11 INR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 9.9 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.33%
- Paid out of profit
- 15%
You receive ₹1.00 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail